- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 7, 2020
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Morning Journal cited a study published in the July 2020 issue of The American Journal of Managed Care® (AJMC®), titled “The Escalation of the Opioid Epidemic Due to COVID-19 and Resulting Lessons About Treatment Alternatives.” The study indicated that investing in modalities that promote building emotional resiliency and help address the factors that made patients susceptible to opioid reliance in the first place are key to addressing the growing opioid epidemic amid the pandemic.
A piece by WGNO spotlighted a study published in the June 2020 issue of AJMC®. The study, “Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program,” found that enrollment in a value-based insurance design program that eliminated pharmacy co-pays for 4 chronic disease drug classes was associated with a large decline in health care spending.
An article by FOX 5 Washington DC referenced a study published in The American Journal of Accountable Care®, the sister journal of AJMC®. The study, “Current Value-Based Care Models Need Greater Emphasis on Specialty Care,” provided an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Challenges in GERD Diagnosis and Treatment: The Need for a Multidisciplinary Approach
January 10th 2025A recent review emphasizes the need for personalized treatment strategies and a multidisciplinary approach to effectively manage the various subtypes of gastroesophageal reflux disease (GERD), highlighting the challenges of diagnosis and treatment, particularly in cases with refractory symptoms.
Read More
